ADDvise Group AB (publ) publishes updated preliminary Pro-forma financials for the ongoing acquisition- Regulatory notice
Updated financials ADDvise has prepared updated preliminary financials to clarify the impact of ADDvise's latest acquisitions on ADDvise's financials, as well as the ongoing acquisition of the previously mentioned Finnish medtech company the (“Company”) expected effect on the financials. ADDvise preliminary full year 2018 (“Prel FY 18”) financials correspond to a net sales growth of 17.7 percent and an EBITDA growth of 18.7 percent compared to fiscal year of 2017. Proforma Prel FY 18 compared to ADDvise Prel FY 18 corresponds to a net sales growth of 25.2 percent and an EBITDA growth of